Navigation Links
Federal government renews contract for collecting and maintaining national stem cell transplantation database
Date:11/1/2012

The Medical College of Wisconsin (MCW) Center for International Blood and Marrow Transplant Research (CIBMTR) successfully competed for, and was awarded, renewal of the Stem Cell Therapeutics Outcomes Database contract with the U.S. Health Resources and Services Administration (HRSA). The CIBMTR administers the database as a key component of the national hematopoietic cell transplantation program. Hematopoietic stem cells are the cells responsible for continual regeneration of circulating blood cells throughout life; they are not embryonic stem cells.

The HRSA first awarded the contract to CIBMTR in 2006 to develop and maintain the national Stem Cell Therapeutic Outcomes Database (SCTOD), which is a standardized outcomes registry of allogeneic (related and unrelated donor cells) marrow and cord blood transplants performed in the United States. Funding for the first year of this new contract is $3.8 million, with an additional four years of negotiable funding.

The outcomes registry of the CIBMTR currently contains the status of 330,000 transplant recipients, as well as critical information to continually evaluate the operations of the national transplant program. All U.S. transplant centers that perform allogeneic marrow and cord blood transplants are required to provide patient outcomes data to the registry.

"CIBMTR is privileged to continue to operate the Outcomes Database on behalf of the C.W. Bill Young Cell Transplantation Program," said J. Douglas Rizzo, M.D., M.S., professor of medicine at MCW, associate scientific director at CIBMTR and principal investigator of the SCTOD. "CIBMTR delivers value by using the Outcomes Database to provide clinicians, scientists, patients and policymakers the information they need to make the best possible clinical decisions. It is a beneficial platform to expand important research to advance the field, plan clinical trials, facilitate quality improvement and perform studies on behalf of policymakers. The major goal of the program is to make blood and marrow transplants available to all who need them, and to increase their safety and effectiveness."

Congress first enacted HRSA's C.W. Bill Young Cell Transplantation Program in 2005, which led to the creation of the Stem Cell Therapeutic Outcomes Database. Congress reauthorized the Program in 2010. It is named after U.S. Congressman C.W. Bill Young of Florida, who was instrumental in founding a national marrow donor registry that could provide potentially life-saving treatment for those diagnosed with leukemia and other blood diseases.

The Medical College's CIBMTR is a partnership formed through an affiliation of the Medical College's International Bone Marrow Transplant Registry and the National Marrow Donor Program (NMDP). Since 1972, the Center has collected outcomes data provided voluntarily by transplant centers worldwide on both allogeneic (related and unrelated donor cells) and autologous (patient's own cells) hematopoietic stem cell transplants, and has made these data available to investigators and physicians worldwide to perform research to advance the field. The CIBMTR has published nearly 800 peer-reviewed papers (more than 45 in the past year alone) and is conducting more than 250 observational studies. It also has helped to coordinate 28 national clinical trials in HCT, 18 of which have completed accrual.

In addition to the Stem Cell Therapeutic Outcomes Database, HRSA recently awarded other C.W. Bill Young Cell Transplantation Program contracts to the NMDP, in order to continue the Program's work as the Office of Patient Advocacy/Single Point of Access for transplant patients, the Bone Marrow Coordinating Center and the Cord Blood Coordinating Center.


'/>"/>

Contact: Rachel Mosey
rmosey@mcw.edu
Medical College of Wisconsin
Source:Eurekalert

Related medicine news :

1. New federal disclosure law may have little impact on drugs prescribed
2. Study examines federal government payments to separate managed care programs for same patients
3. Federally funded clinics for low-income patients as effective as private practices
4. American College of Physicians awarded 3-year federal grant to increase adult immunization rates
5. HHS enlists Archimedes Inc. to expand governments use of health care modeling
6. Most occupational injury and illness costs are paid by the government and private payers
7. Internists recommend principles on role of governments in regulating patient-physician relationship
8. Government can play important role in obesity epidemic
9. Arizona State University secures defense contract
10. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
11. Local Woodinville Contractor, Washington State Kitchen and Bath, Combats Toxic Mold, Adhering to the Toughest Mold Protection Standards in the Nation with New Promotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... DIEGO , Oct. 12, 2017 AVACEN ... recognized the company with their  2017 New Product Innovation Award ... based on extensive primary and secondary medical device market research ... Medical, through its first-to-market OTC, drug-free pain relief product, the ... unique approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology: